CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes

被引：0
|
作者：
Butler, S. L.
Boonsakan, P.
Grier, D. D.
Li, Y.
Braylan, R. C.
Al-Quran, S. Z.
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Wake Forest Univ, Winston Salem, NC 27109 USA
来源：
LABORATORY INVESTIGATION | 2009年 / 89卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1165
引用
收藏
页码：256A / 256A
页数：1
相关论文
共 50 条
  • [1] Expression of CD34 by megakaryocytes In myelodysplastic syndromes
    Pellegrini, W
    Facchetti, F
    Marocolo, D
    Pelizzari, AM
    Capucci, A
    Rossi, G
    [J]. HAEMATOLOGICA, 2000, 85 (10) : 1117 - 1118
  • [2] CD34 Expression by Megakaryocytes in Myelodysplastic Syndromes
    Butler, S. L.
    Boonsakan, P.
    Grier, D. D.
    Li, Y.
    Braylan, R. C.
    Al-Quran, S. Z.
    [J]. MODERN PATHOLOGY, 2009, 22 : 256A - 256A
  • [3] CD34 expression in various FAB subtypes of myelodysplastic syndromes
    Wang, GS
    Shidham, V
    Kampalath, B
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1999, 112 (04) : 560 - 560
  • [4] High-Level CD34 Expression on Megakaryocytes Independently Predicts an Adverse Outcome in Patients with Myelodysplastic Syndromes
    Tang, G.
    Wang, S. A.
    Menon, M.
    Woda, B.
    Hao, S.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 325A - 325A
  • [5] High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes
    Tang, Guilin
    Wang, Sa A.
    Menon, Madhu
    Dresser, Karen
    Woda, Bruce A.
    Hao, Suyang
    [J]. LEUKEMIA RESEARCH, 2011, 35 (06) : 766 - 770
  • [6] High-Level CD34 Expression on Megakaryocytes Independently Predicts an Adverse Outcome in Patients with Myelodysplastic Syndromes
    Tang, G.
    Wang, S. A.
    Menon, M.
    Woda, B.
    Hao, S.
    [J]. MODERN PATHOLOGY, 2011, 24 : 325A - 325A
  • [7] CLINICAL AND PROGNOSTIC SIGNIFICANCE OF CD34 EXPRESSION IN BONE MARROW BIOPSIES IN MYELODYSPLASTIC SYNDROMES
    Savic, A.
    Cemerikovic-Martinovic, V.
    Dinic-Uzurov, V.
    Savic, I.
    Rajic, N.
    Milosevic, I.
    Zeravica, B.
    Urosevic, I.
    Agic, D.
    Vlaisavljevic, N.
    Popovic, S.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 487 - 488
  • [8] EXPRESSION OF CD34 AND P-GLYCOPROTEIN - PROGNOSTIC-SIGNIFICANCE IN PRIMARY MYELODYSPLASTIC SYNDROMES
    RUNDE, V
    GERMING, U
    AUL, C
    [J]. INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (04) : 901 - 905
  • [9] BONE MARROW EXPRESSION OF CD33, CD34 AND CD117 FOR THE PROGNOSTIC ASSESSMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES
    Nador, G.
    Molteni, A.
    Cesana, C.
    Nichelatti, M.
    Scarpati, B.
    Cairoli, R.
    Barbarano, L.
    Riva, M.
    Nosari, A.
    Morra, E.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 290 - 290
  • [10] Abnormalities of myeloblast CD34 and (or) CD117 expression are highly informative in flow cytometric assessment of myelodysplastic syndromes
    Pirruccello, SJ
    Young, KH
    Aoun, P
    [J]. CYTOMETRY PART B-CLINICAL CYTOMETRY, 2005, 68B (01) : 65 - 66
12345